Doxorubicin-Induced Oxidative Injury of Cardiomyocytes - Do We Have Right Strategies for Prevention?

@inproceedings{Torres2012DoxorubicinInducedOI,
  title={Doxorubicin-Induced Oxidative Injury of Cardiomyocytes - Do We Have Right Strategies for Prevention?},
  author={Vukosava Milic Torres and Viktorija Dragojevic Simic},
  year={2012}
}
Anthracyclines are among the most utilised antitumour drugs ever developed. The discovery of one of the leading compounds, doxorubicin (DOX) in early 1960s was a major advance in the fight against cancer. According to the WHO, it belongs to the group of 17 essential drugs that are used to treat curable cancers or cancers for which the cost-benefit ratio clearly favours drug treatment (Sikora et al., 1999). It is used, often with other antineoplastic, in the treatment of Hodgkin's disease, non… CONTINUE READING

Figures and Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 13 CITATIONS

Protective Effect of Taurine on Mice with Doxorubicin-induced Acute Kidney Injury.

  • Advances in experimental medicine and biology
  • 2017
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 196 REFERENCES

Antioxidant properties and hypothetical radical mechanism of fullerenol

A. 119 Djordjevic, J. Canadanovic-Brunet, M. Vojnovic-Miloradov, G. Bogdanovic
  • 2005
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Risk factors for doxorubicin-induced congestive heart failure

D. D. Von Hoff, M. W. Layard, +5 authors F. M. Muggia
  • Ann Intern Med
  • 1979
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL